Suppr超能文献

经心房进入正常心包腔:一种用于诊断性取样、心包穿刺术及治疗性干预的新方法。

Transatrial access to the normal pericardial space: a novel approach for diagnostic sampling, pericardiocentesis, and therapeutic interventions.

作者信息

Verrier R L, Waxman S, Lovett E G, Moreno R

机构信息

Institute for Prevention of Cardiovascular Disease, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.

出版信息

Circulation. 1998 Nov 24;98(21):2331-3. doi: 10.1161/01.cir.98.21.2331.

Abstract

BACKGROUND

A nonsurgical means to access the normal pericardial space could provide opportunities for diagnostic sampling and therapeutic interventions. Because there are currently no approved nonsurgical methods to accomplish this, we tested a new approach in large animals.

METHODS AND RESULTS

A catheter system was employed in a percutaneous approach from a femoral vein to pierce the right atrial appendage. Pericardial access was confirmed by placement of a radiopaque guidewire visible under fluoroscopy (6 dogs, 13 pigs). In 7 of the pigs, pericardial tamponade, produced by injection of saline or heparinized blood into the pericardial space through this route, was confirmed by fluoroscopy and hemodynamic evidence. The feasibility and safety of this access route were tested with multiple repetitions in all 19 animals. At the end of each of the 17 acute experiments, direct inspection after thoracotomy revealed no hemopericardium, laceration, or bleeding on catheter withdrawal. In 24-hour survival studies performed in 2 of the 6 dogs, the animals exhibited no behavioral signs of discomfort or untoward consequences on recovery from anesthesia. Histology revealed only a small (approximately 1-mm) fibrinous plug at the site of puncture.

CONCLUSIONS

The percutaneous approach via the right atrial appendage provides a rapid, safe route to access the normal pericardial space for diagnostic sampling and to alleviate high-volume and low-volume (<200 mL) pericardial effusions. The access route is potentially useful for selective administration of therapeutic agents, growth factors, gene vectors, and cardioactive and vasoactive agents to the heart.

摘要

背景

一种进入正常心包腔的非手术方法可为诊断性采样和治疗干预提供机会。由于目前尚无获批的非手术方法来实现这一目的,我们在大型动物身上测试了一种新方法。

方法与结果

采用一种导管系统,经皮从股静脉穿刺进入右心耳。通过放置在荧光透视下可见的不透射线导丝来确认心包腔通路(6只犬,13头猪)。在7头猪中,通过该途径向心包腔内注射生理盐水或肝素化血液造成心包填塞,经荧光透视和血流动力学证据得以证实。在所有19只动物中多次重复测试了该通路的可行性和安全性。在17次急性实验的每次实验结束时,开胸后直接检查显示在拔出导管后无心包积血、撕裂或出血。在6只犬中的2只进行的24小时存活研究中,动物在从麻醉中恢复后未表现出不适的行为迹象或不良后果。组织学检查显示穿刺部位仅有一个小的(约1毫米)纤维蛋白栓。

结论

经右心耳的经皮途径为进入正常心包腔进行诊断性采样以及缓解大量和少量(<200毫升)心包积液提供了一条快速、安全的途径。该通路可能有助于向心脏选择性给药治疗药物、生长因子、基因载体以及心脏活性和血管活性药物。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验